Fulgent Genetics (FLGT) Total Liabilities (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Total Liabilities for 11 consecutive years, with $106.8 million as the latest value for Q4 2025.
- Quarterly Total Liabilities rose 17.63% to $106.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $106.8 million through Dec 2025, up 17.63% year-over-year, with the annual reading at $106.8 million for FY2025, 17.63% up from the prior year.
- Total Liabilities hit $106.8 million in Q4 2025 for Fulgent Genetics, up from $93.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $197.5 million in Q1 2021 to a low of $83.0 million in Q1 2025.
- Historically, Total Liabilities has averaged $115.5 million across 5 years, with a median of $105.1 million in 2024.
- Biggest five-year swings in Total Liabilities: soared 2383.55% in 2021 and later tumbled 39.54% in 2023.
- Year by year, Total Liabilities stood at $112.8 million in 2021, then rose by 2.96% to $116.2 million in 2022, then decreased by 12.17% to $102.0 million in 2023, then decreased by 11.01% to $90.8 million in 2024, then grew by 17.63% to $106.8 million in 2025.
- Business Quant data shows Total Liabilities for FLGT at $106.8 million in Q4 2025, $93.8 million in Q3 2025, and $88.2 million in Q2 2025.